The MND Unit of the Hospital Universitari i Politècnic La Fe is the referral centre in the Valencian region and one of the referral centres in Spain for MND patients. We are also part of the European Research Network for rare neuromuscular diseases. Our research group is integrated in the Research Group of Neuromuscular Pathology and Ataxias (GIPNMA) and is part of the Spanish network for research in rare diseases (CIBERER). Our main research interests are the phenotypic and genetic characterization of our patient cohort, the search of biomarkers and clinical trials.
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.